Shanghai, China

Yuanchao Xie

This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Chinese Academy of Sciences, Vigonvita Life Sciences Co., Ltd., Shanghai Institute of Materia Medica, Chines Academy of Sciences. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuanchao Xie. Retrieved from https://idiyas.com/inventor/yuanchao-xie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Yuanchao Xie in Antiviral Applications

Introduction

Yuanchao Xie is a notable inventor based in Shanghai, China. He has made significant contributions to the field of antiviral research, particularly through his innovative use of nucleoside analogs. With a total of two patents to his name, Xie's work focuses on developing effective treatments for viral infections.

Latest Patents

Yuanchao Xie's latest patents revolve around the antiviral application of nucleoside analogs. His inventions detail the use of these analogs as inhibitors for the replication of various viruses, including coronaviruses, influenza viruses, and others. The pharmaceutical compositions he has developed aim to treat and prevent diseases caused by these viral infections, including respiratory infections and pneumonia related to COVID-19.

Career Highlights

Throughout his career, Yuanchao Xie has worked with esteemed organizations such as the Chinese Academy of Sciences and Vigonvita Life Sciences Co., Ltd. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Yuanchao Xie has collaborated with notable colleagues, including Gengfu Xiao and Yang He. These partnerships have further enriched his research endeavors and have played a role in the development of his innovative solutions.

Conclusion

Yuanchao Xie's contributions to antiviral research through his patents on nucleoside analogs highlight his commitment to addressing significant health challenges. His work continues to pave the way for advancements in the treatment of viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…